Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

IgG N-glycosylation is not influenced by severity of complications in type 1 diabetes (CROSBI ID 735511)

Prilog sa skupa u zborniku | sažetak izlaganja sa skupa

Plavša, Branimir ; Kološnjaj, Ivona ; Bulum, Tomislav ; Tomić, Martina: Vučković Rebrina, Sandra ; Vučić Lovrenčić, Marijana ; Duvnjak, Lea ; Gornik, Olga IgG N-glycosylation is not influenced by severity of complications in type 1 diabetes. 2022. str. 120-121

Podaci o odgovornosti

Plavša, Branimir ; Kološnjaj, Ivona ; Bulum, Tomislav ; Tomić, Martina: Vučković Rebrina, Sandra ; Vučić Lovrenčić, Marijana ; Duvnjak, Lea ; Gornik, Olga

engleski

IgG N-glycosylation is not influenced by severity of complications in type 1 diabetes

N-glycosylation of immunoglobulin G (IgG) is known to influence the antibody function. Changes in IgG N-glycome associate with many inflammatory conditions and were reported in early stages of type 1 and type 2 diabetes mellitus (DM). IgG N- glycosylation was also studied in relation to disease progression in type 2 DM and was found to associate with diabetes complications. Although type 1 and type 2 DM share complications, these findings may not apply to type 1 DM due to different pathophysiology involved and a longer disease duration prior to complication manifestation.

glycosylation, N-glycosylation, IgG, diabetes, type 1

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

120-121.

2022.

objavljeno

Podaci o matičnoj publikaciji

Podaci o skupu

HDBMB 2022 Congress – From Science to Knowledge

poster

28.09.2022-01.10.2022

Brela, Hrvatska

Povezanost rada

Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)